Relief Therapeutics Holding AG (RLFTF)

[aGuyUS]

ClinicalTrials.gov Identifier: NCT04311697
AKA "Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (COVID-AIV)"
Recruitment Status : Recruiting
First Posted : March 17, 2020
[color=red]Last Update Posted : August 31, 2020[/color]

THE DMC I believe met may have met and made a determination as the Study was Updated August 27

The Link Below Shows a side by side comparison of July 27 module V.12 and the August 27 Module v 13

https://clinicaltrials.gov/ct2/history/NCT04311697?B=13&A=14&C=Side-by-Side#StudyPageTop


Green highlights in the comparison are Additions
Red highlights in the comparison are deletions

All deletions are on the Left Document and All Additions are on the Right document. This suggests to me they met in August as they were supposed to and made a decision to Continue the trial without changing the Trial study from the July 27 Module